Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC0950 Berotralstat Hydrochloride

Novel selective inhibitor of plasma kallikrein, blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE

1809010-52-3
DCC0951 Beta-blocker-15

Novel negative allosteric modulator of the ß2-adrenergic receptor (ß2AR), inhibiting cAMP production through the ß2AR, but not that mediated by other Gs-coupled receptors, also inhibiting ß-arrestin recruitment to the activated ß2AR

DCC0952 Beta-cit-fp

Potent ligand of the serotonin (5-HT) and dopamine (DA) transporters used in diagonisis of Parkinson's disease as SPECT imaging precursor

155797-99-2
DCC0953 Beta-erythroidine Hcl

Phytoestrogen, possessing typical curare-like action

596-11-2
DCC0954 Beta-nor-lapachone

Natural antibiofilm agent and adjuvant on the antifungal therapy related to resistant infections caused by C. glabrata

52436-88-1
DCC0955 Betaxolol

Selective beta-1 adrenergic receptor antagonist with antihypertensive and anti-glaucoma activities and devoid of intrinsic sympathomimetic activity

63659-18-7
DCC0956 Bet-brd7/9 Inhibitor-12

Novel Dual BET-BRD7/9 Bromodomain Inhibitor, showing a strong antiproliferative effect on various cancer cell lines that could not be observed for BD family selective inhibitors

DCC0957 Bet-in-36

Novel BET inhibitor, selectively targeting BRD4-BD1 bromodomain

DCC0958 Betulinic Acid Hydroxamate

Novel HIF Prolyl Hydrolase Inhibitor, preventing colonic inflammation and fibrosis in murine models of inflammatory bowel disease

DCC0959 Bf-170 Hydrochloride

Novel probe for neurofibrillary tangles (tau fibrils)

22191-97-5
DCC0960 Bff122

Novel potent and selective inhibitor of kynurenine aminotransferase II

1152314-49-2
DC90961 Bff-816 Featured

Novel, systemically active kynurenine aminotransferase 2 (KAT2) inhibitor, significantly decreased escape latency in the Morris water maze, indicating improved performance in spatial and contextual memorynovel

2008006-36-6
DCC0962 b-gf-15

Potent inhibitor of centrosomal clustering in malignant cells

1888042-13-5
DCC0963 b-glucogallin

Novel Aldose_reductase_inhibitor>aldose reductase (ALR2) inhibitor

13405-60-2
DCC0964 Bg-p400-tat

Novel dual inhibitor of norepinephrine transporter (NET) function and thyrointegrin αvβ3 receptor

DCC0965 Bgt1-in-9

The first small-molecule substrate identified with high selectivity for BGT1 over the three other GAT subtypes; M1 muscarinic agonist

185444-92-2
DCC0966 Bh3i-2

Cell-permeable apoptosis inducer, specifically preventing BH3 domain-mediated interactions between pro-apoptotic and anti-apoptotic members of the Bcl-2 family

DCC0967 Bhq-2-succinimide Ester

Reactive dark quencher used in a variety of Fluorescence Resonance Energy Transfer (FRET) DNA detection probe.

916753-62-3
DCC0968 Bhq-o-5ht

Novel photoactivatable form of serotonin

1417436-52-2
DCC0969 Bi-0319

Novel PROTAC (proteolysis-targeting chimera) as a PTK2 protein degerader

DCC0970 Bi-1750

Novel fluorophore substrate of the protease Cathepsin C (CatC), being highly selective versus the related proteases CatB, CatF, CatH, CatK, CatL and CatS

DCC0971 Bi-1942

Novel potent inhibitor of human chymase with >100 fold selectivity against Cathepsin G

Page 1265 / Total 1557 FirstPrevNextLastGoto